HuGE Literature Finder
Records 1-30
|
Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy.
Anticancer research 2021 Feb 41 (2): 829-834. Nakamura Masaki, Kageyama Shun-Ichiro, Seki Masahide, Suzuki Ayako, Okumura Masayuki, Hojo Hidehiro, Motegi Atsushi, Akimoto Tets |
|
Characterization of genomic alterations in Chinese colorectal cancer patients.
Japanese journal of clinical oncology 2020 Oct . Huang Wei, Li Hui, Shi Xiaoliang, Lin Minglin, Liao Cun, Zhang Shuirong, Shi Weiwei, Zhang Lin, Zhang Xiaolong, Gan Jialia |
|
Early-onset colorectal cancer: A distinct entity with unique genetic features.
Oncology letters 2020 Oct 20 (4): 33. Jiang Dan, Shu Chang, Lei Chuanfen, Wan Ying, Sun Linyo |
|
Frequency and Coexistence of KRAS, NRAS, BRAF, and PIK3CA Mutations and occurrence of MMR deficiency in Danish Colorectal Cancer Patients.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2020 Oct . Poulsen Tim Svenstrup, de Oliveira Douglas Vinicius Nogueira Perez, Espersen Maiken Lise Marcker, Klarskov Louise Laurberg, Skovrider-Ruminski Wojciech, Hogdall Estr |
|
KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: A single-site report.
Translational oncology 2020 Sep 13 (12): 100874. Luo Qianxin, Chen Dianke, Fan Xinjuan, Fu Xinhui, Ma Tenghui, Chen Dai |
|
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.
European journal of cancer (Oxford, England : 1990) 2020 Aug 137 250-259. Stahler Arndt, Stintzing Sebastian, von Einem Jobst C, Westphalen Christoph B, Heinrich Kathrin, Krämer Nicole, Michl Marlies, Modest Dominik P, von Weikersthal Ludwig Fischer, Decker Thomas, Kiani Alexander, Heintges Tobias, Kahl Christoph, Kullmann Frank, Scheithauer Werner, Moehler Markus, Kaiser Florian, Kirchner Thomas, Jung Andreas, Heinemann Volk |
|
Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2020 Jul 42 (7): 1010428320938492. Wielandt Ana María, Hurtado Claudia, Moreno C Mauricio, Villarroel Cynthia, Castro Magdalena, Estay Marlene, Simian Daniela, Martinez Maripaz, Vial Maria Teresa, Kronberg Udo, López-Köstner Francis |
|
Prognostic value of molecular biomarkers in patients with metastatic colorectal cancer: a real-world study.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2020 Jun . García-Alfonso P, García-González G, Gallego I, Peligros M I, Ortega L, Torres Pérez-Solero G, Sandoval C, Muñoz Martin A, Blanco Codesido M, Calvo Ferrándiz A, Martin |
|
Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component.
BMC cancer 2020 May 20 (1): 400. Li Xiaodong, Sun Katherine, Liao Xiaoyan, Gao Haijuan, Zhu Hongfa, Xu Rulia |
|
Targeted next generation sequencing of MLH1-deficient, MLH1 promoter hypermethylated and BRAF/RAS-wild-type colorectal adenocarcinomas is effective in detecting tumors with actionable oncogenic gene fusions.
Genes, chromosomes & cancer 2020 May . VaNková Bohuslava, VanEcek Tomáš, Ptáková Nikola, Hájková Veronika, Dušek Martin, Michal Michael, Švajdler Peter, Daum OndRej, Daumová Magdaléna, Michal Michal, Mezencev Roman, Švajdler Mari |
|
Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan.
Translational oncology 2020 May 13 (7): 100786. Taniguchi Hiroya, Uehara Keisuke, Nakayama Goro, Nakayama Hiroshi, Aiba Toshisada, Hattori Norifumi, Kataoka Masato, Nakano Yasuyuki, Kawase Yoshihisa, Okochi Osamu, Matsuoka Hiroshi, Utsunomiya Setsuo, Sakamoto Eiji, Mori Yoshinori, Umeda Shinichi, Shikano Toshio, Komori Koji, Tajika Masahiro, Kadowaki Shigenori, Muro Kei, Yatabe Yasus |
|
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected.
Clinical colorectal cancer 2020 Mar . Sastre Javier, Orden Virginia de la, Martínez Antonio, Bando Inmaculada, Balbín Milagros, Bellosillo Beatriz, Palanca Sarai, Peligros Gomez Maria Isabel, Mediero Beatriz, Llovet Patricia, Moral Virginia Moreno, Viéitez José Maria, García-Alfonso Pilar, Calle Silvia Gil, Ortiz-Morales Maria José, Salud Antonieta, Quintero Guillermo, Lopez Carlos, Díaz-Rubio Eduardo, Aranda Enrique, |
|
High mutational concordance between primary colorectal tumors and associated pulmonary metastases.
Journal of surgical oncology 2020 Feb . Corsini Erin M, Datar Saumil S, Mitchell Kyle G, Zhou Nicolas, Hofstetter Wayne L, Mehran Reza J, Rajaram Ravi, Rice David C, Roth Jack A, Sepesi Boris, Swisher Stephen G, Vaporciyan Ara A, Walsh Garrett L, Blackmon Shanda H, Loree Jonathan M, Morris Van K, Antonoff Mara |
|
Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
BMC cancer 2020 Jan 20 (1): 72. Manoharan Vahinipriya, Karunanayake Eric Hamilton, Tennekoon Kamani Hemamala, De Silva Sumadee, Imthikab Ahamed Ilyas Ahamed, De Silva Kanishka, Angunawela Preethika, Vishwakula Sameera, Lunec Jo |
|
Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis.
Cancer medicine 2019 Nov . Ye Zu-Lu, Qiu Miao-Zhen, Tang Tao, Wang Fang, Zhou Yi-Xin, Lei Meng-Jie, Guan Wen-Long, He Cai-Y |
|
Fecal Genetic Mutations and Human DNA in Colorectal Cancer and Polyps Patients.
Asian Pacific journal of cancer prevention : APJCP 2019 Oct 20 (10): 2929-2934. Lima Jacqueline, Teixeira Yolanda, Pimenta Célia, Felipe Aledson Vitor, Silva Tiago Donizetti, Junior Ermelindo Ermelindo Della Libera, Saad Sarhan Sydney, Deak Elisabeth, Murray Helena, Manoukian Forones No |
|
Mutation profiling of cancer drivers in Brazilian colorectal cancer.
Scientific reports 2019 Sep 9 (1): 13687. Dos Santos Wellington, Sobanski Thais, de Carvalho Ana Carolina, Evangelista Adriane Feijó, Matsushita Marcus, Berardinelli Gustavo Nóriz, de Oliveira Marco Antonio, Reis Rui Manuel, Guimarães Denise Peixo |
|
Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients.
Clinical chemistry and laboratory medicine 2019 Jul . Wang Beili, Wu Shengchao, Huang Fei, Shen Minna, Jiang Huiqin, Yu Yiyi, Yu Qian, Yang Yihui, Zhao Ying, Zhou Yiwen, Pan Baishen, Liu Tianshu, Guo W |
|
Impact of genetic mutations and nutritional status on the survival of patients with colorectal cancer.
BMC cancer 2019 Jun 19 (1): 644. Cavagnari Mariana Abe Vicente, Silva Tiago Donizetti, Pereira Marco Antonio Haddad, Sauer Luísa Jacques, Shigueoka David, Saad Sarhan Sydney, Barão Katia, Ribeiro Carla Caroline Dias, Forones Nora Manouki |
|
[Combined detection of KRAS, NRAS, BRAF and PIK3CA mutations in the plasma and tumor tissues of colorectal cancer patients].
Zhonghua bing li xue za zhi = Chinese journal of pathology 2019 May 48 (5): 373-377. Liu X N, Tian Z, Wei X F, Wang Q, Zhang J X, Jin M S, Duan X |
|
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.
Annals of oncology : official journal of the European Society for Medical Oncology 2019 May 30 (5): 796-803. Santos C, Azuara D, Viéitez J M, Páez D, Falcó E, Élez E, López-López C, Valladares M, Robles-Díaz L, García-Alfonso P, Bugés C, Durán G, Salud A, Navarro V, Capellá G, Aranda E, Salazar |
|
Calcium intake and colon cancer risk subtypes by tumor molecular characteristics.
Cancer causes & control : CCC 2019 Apr . Keum NaNa, Liu Li, Hamada Tsuyoshi, Qian Zhi Rong, Nowak Jonathan A, Cao Yin, da Silva Annacarolina, Kosumi Keisuke, Song Mingyang, Nevo Daniel, Wang Molin, Chan Andrew T, Meyerhardt Jeffrey A, Fuchs Charles S, Wu Kana, Ogino Shuji, Nishihara Reiko, Zhang Xueho |
|
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer.
Journal of translational medicine 2019 Apr 17 (1): 137. Isnaldi Edoardo, Garuti Anna, Cirmena Gabriella, Scabini Stefano, Rimini Edoardo, Ferrando Lorenzo, Lia Michela, Murialdo Roberto, Tixi Lucia, Carminati Enrico, Panaro Andrea, Gallo Maurizio, Grillo Federica, Mastracci Luca, Repetto Lazzaro, Fiocca Roberto, Romairone Emanuele, Zoppoli Gabriele, Ballestrero Alber |
|
RNA sequencing reveals PNN and KCNQ1OT1as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
International journal of cancer 2019 Apr . Mini Enrico, Lapucci Andrea, Perrone Gabriele, D'Aurizio Romina, Napoli Cristina, Brugia Marco, Landini Ida, Tassi Renato, Picariello Lucia, Simi Lisa, Mancini Irene, Messerini Luca, Magi Alberto, Pinzani Pamela, Mazzei Teresita, Tonelli Francesco, Nobili Stefan |
|
Clinicopathological and molecular differences in colorectal cancer according to location.
The International journal of biological markers 2019 Mar 1724600818807164. Hsu Yu-Lun, Lin Chun-Chi, Jiang Jeng-Kai, Lin Hung-Hsin, Lan Yuan-Tzu, Wang Huann-Sheng, Yang Shung-Haur, Chen Wei-Shone, Lin Tzu-Chen, Lin Jen-Kou, Lin Pei-Ching, Chang Shih-Chi |
|
Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy.
BMC cancer 2019 Mar 19 (1): 255. Harada Kazuaki, Okamoto Wataru, Mimaki Sachiyo, Kawamoto Yasuyuki, Bando Hideaki, Yamashita Riu, Yuki Satoshi, Yoshino Takayuki, Komatsu Yoshito, Ohtsu Atsushi, Sakamoto Naoya, Tsuchihara Katsu |
|
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.
Annals of oncology : official journal of the European Society for Medical Oncology 2019 Mar . Santos C, Azuara D, Viéitez J M, Páez D, Falcó E, Élez E, López-López C, Valladares M, Robles-Díaz L, García-Alfonso P, Bugés C, Durán G, Salud A, Navarro V, Capellá G, Salazar R, Aranda |
|
Ultra-selection of metastatic colorectal cancer patients using Next Generation Sequencing to improve clinical efficacy of anti-EGFR therapy.
Annals of oncology : official journal of the European Society for Medical Oncology 2019 Jan . Vidal J, Bellosillo B, Santos Vivas C, García-Alfonso P, Carrato A, Cano M T, García-Carbonero R, Élez E, Losa F, Massutí B, Valladares-Ayerbes M, Viéitez J M, Manzano J L, Gallego J, Pairet S, Capellá G, Salazar R, Tabernero J, Aranda E, Montagut |
|
High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer.
Asian Pacific journal of cancer prevention : APJCP 2019 08 20 (8): 2319-2326. Korphaisarn Krittiya, Pongpaibul Ananya, Roothumnong Ekkapong, Pongsuktavorn Khontawan, Thamlikitkul Lucksamon, Anekpuritanang Tauangtham, Poungvarin Naravat, Thongnoppakhun Wanna, Pithukpakorn Man |
|
Prevalence and prognostic role of PIK3CA E545K mutation in Iranian colorectal cancer patients.
Gastroenterology and hepatology from bed to bench 2019 12 (Suppl1): S22-S29. Ranjbar Reza, Mohammadpour Somayeh, Torshizi Esfahani Amir, Namazian Sina, Yaghob-Taleghani Mohammad, Baghaei Kaveh, Mortazavi Tabatabaei Seyed Abdolreza, Pasharavesh Leila, Nazemalhosseini-Mojarad Ehs |
- Page last reviewed:Oct 1, 2020
- Page last updated:Feb 24, 2021
- Content source: